相似文献
1
Conformationally homogeneous heterocyclic pseudotetrapeptides as three-dimensional scaffolds for rational drug design: receptor-selective somatostatin analogues.
Angew Chem Int Ed Engl. 2009;48(26):4725-9. doi: 10.1002/anie.200805901.
2
Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.
J Med Chem. 2003 Dec 18;46(26):5606-18. doi: 10.1021/jm030246p.
3
Molecular modeling suggests conformational scaffolds specifically targeting five subtypes of somatostatin receptors.
Chem Biol Drug Des. 2007 Mar;69(3):163-9. doi: 10.1111/j.1747-0285.2007.00493.x.
4
Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
J Med Chem. 2003 Dec 18;46(26):5587-96. doi: 10.1021/jm0302445.
5
Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
J Med Chem. 2003 Dec 18;46(26):5579-86. doi: 10.1021/jm030243c.
6
Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
J Med Chem. 2003 Dec 18;46(26):5597-605. doi: 10.1021/jm030245x.
7
A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential.
J Med Chem. 2003 Jun 5;46(12):2334-44. doi: 10.1021/jm021093t.
8
Decahydroisoquinoline derivatives as novel non-peptidic, potent and subtype-selective somatostatin sst(3) receptor antagonists.
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1728-34. doi: 10.1016/j.bmcl.2010.01.063. Epub 2010 Jan 21.
9
Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR.
J Med Chem. 2006 Jul 27;49(15):4487-96. doi: 10.1021/jm060363v.
10
A light-activated beta-turn scaffold within a somatostatin analog: NMR structure and biological activity.
Chem Biol Drug Des. 2006 Feb;67(2):127-36. doi: 10.1111/j.1747-0285.2005.00337.x.
引用本文的文献
1
Chemoselective, regioselective, and positionally selective fluorogenic stapling of unprotected peptides for cellular uptake and direct cell imaging.
Chem Sci. 2024 Nov 5;16(2):584-595. doi: 10.1039/d4sc04839c. eCollection 2025 Jan 2.
2
Macrocyclic Triazolopeptoids: A Promising Class of Extended Cyclic Peptoids.
Org Lett. 2022 Oct 28;24(42):7752-7756. doi: 10.1021/acs.orglett.2c03062. Epub 2022 Oct 12.
3
Synthesis of novel cyclopeptides containing heterocyclic skeletons.
RSC Adv. 2018 Oct 3;8(59):33893-33926. doi: 10.1039/c8ra03899f. eCollection 2018 Sep 28.
4
1,2,3-Triazoles as Biomimetics in Peptide Science.
Molecules. 2021 May 14;26(10):2937. doi: 10.3390/molecules26102937.
5
Molecular Self-Assembly and Supramolecular Chemistry of Cyclic Peptides.
Chem Rev. 2021 Nov 24;121(22):13936-13995. doi: 10.1021/acs.chemrev.0c01291. Epub 2021 May 3.
6
1,4-Disubstituted 1,2,3-Triazoles as Amide Bond Surrogates for the Stabilisation of Linear Peptides with Biological Activity.
Molecules. 2020 Aug 6;25(16):3576. doi: 10.3390/molecules25163576.
7
Tailored therapeutics based on 1,2,3-1-triazoles: a mini review.
Medchemcomm. 2019 May 14;10(8):1302-1328. doi: 10.1039/c9md00218a. eCollection 2019 Aug 1.
8
1,4-Disubstituted 1-1,2,3-Triazole Containing Peptidotriazolamers: A New Class of Peptidomimetics With Interesting Foldamer Properties.
Front Chem. 2019 Mar 26;7:155. doi: 10.3389/fchem.2019.00155. eCollection 2019.
9
Bridged bicyclic peptides as potential drug scaffolds: synthesis, structure, protein binding and stability.
Chem Sci. 2015 Oct 1;6(10):5473-5490. doi: 10.1039/c5sc01699a. Epub 2015 Jul 13.
10
Oxadiazole grafts in peptide macrocycles.
Nat Chem. 2016 Dec;8(12):1105-1111. doi: 10.1038/nchem.2636. Epub 2016 Oct 24.
本文引用的文献
1
Probing the bioactive conformation of an archetypal natural product HDAC inhibitor with conformationally homogeneous triazole-modified cyclic tetrapeptides.
Angew Chem Int Ed Engl. 2009;48(26):4718-24. doi: 10.1002/anie.200805900.
2
Design, synthesis, biological evaluation, and structural characterization of potent histone deacetylase inhibitors based on cyclic alpha/beta-tetrapeptide architectures.
J Am Chem Soc. 2009 Mar 4;131(8):3033-41. doi: 10.1021/ja809508f.
3
A series of potent and selective, triazolylphenyl-based histone deacetylases inhibitors with activity against pancreatic cancer cells and Plasmodium falciparum.
J Med Chem. 2008 Jun 26;51(12):3437-48. doi: 10.1021/jm701606b.
4
New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations.
J Med Chem. 2008 Feb 14;51(3):689-93. doi: 10.1021/jm701292s. Epub 2008 Jan 15.
5
Trisubstituted 1,2,4-triazoles as ligands for the ghrelin receptor: on the significance of the orientation and substitution at position 3.
Bioorg Med Chem Lett. 2008 Jan 1;18(1):164-8. doi: 10.1016/j.bmcl.2007.10.113. Epub 2007 Nov 4.
6
The 1,2,3-triazole ring as a peptido- and olefinomimetic element: discovery of click vanilloids and cannabinoids.
Angew Chem Int Ed Engl. 2007;46(48):9312-5. doi: 10.1002/anie.200703590.
7
Click chemistry as a macrocyclization tool in the solid-phase synthesis of small cyclic peptides.
Org Lett. 2007 Nov 22;9(24):5011-4. doi: 10.1021/ol702228u. Epub 2007 Oct 23.
8
Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations.
J Med Chem. 2007 Nov 15;50(23):5790-806. doi: 10.1021/jm0704550. Epub 2007 Oct 10.
9
Peptidomimetics via copper-catalyzed azide-alkyne cycloadditions.
Chem Soc Rev. 2007 Oct;36(10):1674-89. doi: 10.1039/b701444a. Epub 2007 Jun 12.
10
Molecular modeling suggests conformational scaffolds specifically targeting five subtypes of somatostatin receptors.
Chem Biol Drug Des. 2007 Mar;69(3):163-9. doi: 10.1111/j.1747-0285.2007.00493.x.
Zotero 插件